|
|
Vaccines (for HIV Prevention)
The Basics
- Statement of Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day (May 18, 2008)
From National Institute of Allergy and Infectious Diseases
- 2008 AVAC Report The Search Must Continue (May 2008)
From AIDS Vaccine Advocacy Coalition
- Scientists No Closer to Developing HIV Vaccine Than 20 Years Ago, AAAS President Says (February 19, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- An Update Regarding the HVTN 502 and HVTN 503 HIV Vaccine Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- Questions and Answers: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- Philadelphia Inquirer Examines Effect of Merck's Failed International HIV Vaccine Trial on Research and Development (October 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Why Is There Still No Vaccine for HIV? (Summer 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
- NIAID Statement on HIV Vaccine Awareness Day (May 18, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges (May 16, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- On HIV Vaccine Awareness Day, Researchers and Activists Mark 10 Years of Hunting (May 11, 2007)
In Southern Voice
- NIAID Statement on HIV Vaccine Awareness Day, May 18, 2006 (May 15, 2006)
Dr. Anthony Fauci and colleagues urge greater funding and support for vaccine development.
From U.S. National Institute of Allergy and Infectious Diseases
- Leading HIV Vaccine Researcher Emilio Emini Leaves International AIDS Vaccine Initiative for Wyeth (November 4, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Black People and the Search for an HIV Vaccine (November/December 2005)
African-American vaccine advocate Steve Wakefield addresses some common myths African Americans may hold about HIV vaccines.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Even an Imperfect HIV Vaccine Can Save Millions of Lives, Report Says (PDF) (October 2005)
From International AIDS Vaccine Initiative
- Preventive Technologies Pipeline: Vaccines (September 29, 2005)
In TAGline, from Treatment Action Group
- Why Does an Effective HIV Vaccine Remain Elusive? (August 25, 2005)
University of Michigan Medical School professor Howard Markel, M.D., Ph.D., explains some of the roadblocks.
In New England Journal of Medicine
- Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research (August 8, 2005)
Widespread misconceptions about HIV vaccines; most Americans support vaccine research, but do not support vaccine study participation.
From U.S. National Institute of Allergy and Infectious Diseases
- Science Magazine Examines Feasibility of HIV Vaccine (July 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- AIDS Vaccine Handbook, 2nd Edition: Global Perspectives (May 2005)
A comprehensive overview of the key scientific, policy, social, ethical and economic challenges to creating an AIDS vaccine
To read PDF, click here.
From AIDS Vaccine Advocacy Coalition
- HIV Vaccines: Questions and Answers for HIV Treatment Advocates (February 23, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
- African Americans: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
- Health Care Professionals: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
- HIV Vaccines Explained (PDF) (January 2005)
Making HIV vaccines a reality.
From National Institute of Allergy and Infectious Diseases
- Women: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
- Myths About HIV Vaccines and Vaccine Research (PDF) (December 7, 2004)
A fact sheet that addresses African Americans' misconceptions about HIV vaccine research.
From Black AIDS Institute
- Battling the Enemy on Many Fronts: Inside the Science of HIV Vaccine Development (December 2004)
In Body Positive, from Body Positive
- HIV Vaccine Development and Volunteering for Vaccine Trials (December 2004)
An interview with Dr. Beryl Koblin, principal investigator for Project ACHIEVE, an AIDS vaccine advocacy organization in New York City.
In Body Positive, from Body Positive
- Challenges in Designing HIV Vaccines (May 2004)
From U.S. National Institute of Allergy and Infectious Diseases
- HIV Vaccines and Your Immune System (May 2004)
From Project Inform
- HIV Vaccine Not Likely in Next Decade, UNAIDS Executive Director Says (March 23, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Interview With Peggy Johnston, Ph.D., on the Current State of Vaccine Research (Spring 2004)
Dr. Johnston is the Director of AIDS Vaccine Research and Prevention at NIAID.
In Positives for Positives, from Wyoming: Positives for Positives
- Understanding Vaccines: What They Are, How They Work (PDF) (July 2003)
From National Institute of Allergy and Infectious Diseases
- Don't Expect AIDS Vaccine Before 2009, Experts Say (June 19, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- On the Trail of a Vaccine: An Interview With David M. Gold, J.D. (September/October 2002)
In Positive Living, from AIDS Project Los Angeles
- Hope in a Vial: Will There Be an AIDS Vaccine Anytime Soon? (June 2002)
A fabulous analysis of the current vaccine situation.
In Scientific American
- Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AIDS Fighters Redouble Vaccine Effort (November 2001)
In Body Positive, from Body Positive
- HIV Vaccine: How Close Are We? (November 2001)
In OUTReach, from San Francisco AIDS Foundation
- AIDS Vaccine Update (October 1, 2001)
In Being Alive
- HIV 101: HIV Vaccine Candidates (October 2001)
To read PDF, click here
In HEPP News, from Brown Medical School
- Vaccines: Major Conference Sept. 5-8 in Philadelphia (July 27, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
- Susan Dentzer Reports on the Latest Efforts to Create a Vaccine Against AIDS (June 27, 2001)
In PBS MacNeil-Lehrer News Hour
- AIDS Vaccines: The Ethical and Social Issues (Summer 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vaccines Therapy (May 2001)
From AIDS Community Research Initiative of America
- AIDS Vaccine Development (February 9, 2001)
From HIV InSite
- A Media Handbook for HIV Vaccine Trials for Africa (PDF) (February 2001)
From UNAIDS
- How Close Is the AIDS Vaccine? (November 13, 2000)
In Fortune Magazine
- Booster Shot: A Vaccine Primer and Update (November/December 2000)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- HIV Vaccine Glossary (May 2000)
From U.S. National Institute of Allergy and Infectious Diseases
- AIDS Vaccine 2001 Conference
- The Economics of AIDS Vaccines
- The Global Alliance to Immunize Against AIDS
Clinical Trials
- International AIDS Vaccine Research Database of AIDS Vaccines in Human Trials (Regularly Updated)
From International AIDS Vaccine Initiative
- Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Large-Scale Trial of Merck's Experimental HIV Vaccine to Begin in South Africa (February 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- NIH Launches Phase II Trial of HIV Vaccine for Three Strains of Virus (October 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Indian Government Approves Another HIV Vaccine for Phase I Clinical Trial (July 18, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- India Begins Phase I Clinical Trial for HIV Vaccine Targeting C Strain (February 8, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- NIAID Begins Enrolling Volunteers for Novel HIV Vaccine Study (January 24, 2005)
A news release announcing the launch of this Phase II trial, called the Step Study; worldwide study locations and eligibility criteria are listed.
From U.S. National Institute of Allergy and Infectious Diseases
- Timeline for the Initiation of the RV144 Prime-Boost Trial (January 2005)
In TAGline, from Treatment Action Group
- Before You Volunteer for an HIV Vaccine Trial ... (December 2004)
Some key points to consider before you sign those enrollment forms.
In Body Positive, from Body Positive
- Here's My Arm: My Personal Experience Participating in an HIV Vaccine Trial (December 2004)
By Gloria Abitol.
In Body Positive, from Body Positive
- HIV Vaccine Development and Volunteering for Vaccine Trials (December 2004)
An interview with Dr. Beryl Koblin, principal investigator for Project ACHIEVE, an AIDS vaccine advocacy organization in New York City.
In Body Positive, from Body Positive
- Keeping Hope Alive: Myths and Facts About HIV Vaccine Trials (December 2004)
Communicating the basic concepts around HIV vaccine development involves understanding some simple ideas.
In Body Positive, from Body Positive
- Treatment Action Group Criticizes U.S.-Sponsored RV144 ALVAC/AIDSVAX "Prime-Boost" Vaccine Trial in Thailand (September 28, 2004)
In TAGline, from Treatment Action Group
- For HIV-Negative People, the Time to Get Involved Is Now (July/August 2004)
HIV-negative people can play a pivotal role in the development of an HIV vaccine by taking part in early clinical trials.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- One Step Forward: Merck Vaccine Moves Forward With Efficacy Trial, While Special Committee Tries to Salvage Thai Study (July 2004)
In TAGline, from Treatment Action Group
- ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas (June 30, 2004)
In AIDS Treatment News, from AIDS Treatment News
- Thailand to Present Vaccine Results From Phase III HIV Vaccine Trial During XV International AIDS Conference (June 9, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Joining a Preventive HIV Vaccine Clinical Trial: Benefits and Risks (May 2004)
To read PDF, click here
In WISE Words, from Project Inform
- Rwanda to Join African Trials for AIDS Vaccine (March 15, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Chiron Begins Human Clinical Trials of Combination of Two HIV Vaccines (January 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Group of Scientists Questions Value, Cost of Federally Funded AIDS Vaccine Trial in Thailand (January 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- U.S. Government Defends RV 144, an Ongoing HIV Vaccine Efficacy Trial in Thailand (January 15, 2004)
From U.S. National Institute of Allergy and Infectious Diseases
- The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light (October 2003)
Further analysis of AIDSVAX's efficacy -- or lack thereof -- in minorities.
In TAGline, from Treatment Action Group
- Merck HIV Vaccines Progress Through Safety Trials (September 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- South Africa's Medicines Control Council Approves Country's Second HIV Vaccine Clinical Trial (August 27, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Botswana Human Rights Group Says Country Offers No Protection to Participants in HIV Vaccine Trial (August 19, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- U.S. Company Denies Plan to Abandon AIDS Vaccine Test in Thailand (July 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Race Is On to Save the First AIDS Vaccine. But Does It Even Work? (July 1, 2003)
VaxGen pulls out of a final set of trials for its AIDSVAX vaccine amid claims of hype and manipulation.
In The Guardian
- South Africa to Test First Vaccine Against HIV Subtype C (June 20, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Biotech Firm to Test AIDS Vaccine (June 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Italian HIV Vaccine Trial Ready to Begin (June 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Australian-Developed HIV Vaccine Trial Announced (June 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Trials of AIDS Vaccine to Start in India (May 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Debate Over Vaccine Trial Results Hits Racial Divide (April 1, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- A Worthwhile Test of Hope; Despite Negative Results, Subjects Are Glad They Volunteered for AIDS Vaccine Trial (March 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Against the Odds, Company Works on AIDS Vaccine (November 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First Human Trial of "Global" HIV Vaccine Launched (November 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New HIV Vaccine Holds Promise of Global Effectiveness (November 13, 2002)
From U.S. National Institutes of Health
- Clinical Trials of India-Specific Anti-AIDS Vaccine to Start in 2003 (April 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Arizonans to Take Part in Study for an AIDS Vaccine (March 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Albany-Area AIDS Vaccine Testers Needed for Study at Albany Medical College (March 19, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Maryland: Institute of Human Virology Plans Clinical Trial of AIDS Vaccine (March 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- NIAID Phase III HIV Vaccine Trial in the United States Will Not Proceed (March 11, 2002)
Further explanation for why one of the U.S. government's two vaccine trials is being called off.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- A Treatment Issues Editorial: Canarypox in the Coal Mine (March 2002)
The dangers of moving ahead with huge vaccine trials before the science supports them.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases
- First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial (October 9, 2001)
From National Institute of Allergy and Infectious Diseases
- Vaccine Advance: Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway (March 2001)
In TAGline, from Treatment Action Group
- First HIV Vaccine for Africa Begins Trials (January 26, 2001)
In AIDS Treatment News, from AIDS Treatment News
- New Oral DNA Vaccine Funded for Trials (June 2, 2000)
A new kind of vaccine uses a harmless bacterium to deliver selected parts of HIV to immune cells in the intestinal membranes.
In AIDS Treatment News, from AIDS Treatment News
Initiatives & Recommendations
- TAG's Response to NIAID "Request for Information" on Priorities in Basic HIV Vaccine Research (June 4, 2008)
From Treatment Action Group
- PAVE Gives Pause: Position Statement on the Proposed PAVE100A Vaccine Trial (May 30, 2008)
From Treatment Action Group
- Updated, Annotated Preventive Vaccine Pipeline Table (May 29, 2008)
Information on the current preventive HIV vaccine pipeline, annotated with commentary and links to published and presented data.
From Treatment Action Group
- More Human Clinical Research on HIV Vaccine Needed to Find "Magic Formula," Says Opinion Piece (April 14, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Newspapers Publish Opinion Piece, Letter to Editor Responding to Suggestions on Future of HIV Vaccine Research (April 11, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIV/AIDS Vaccine Researchers at NIH Meeting Call for Increase in Basic Research, New Strategies (March 26, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- U.S. Should Fund HIV/AIDS Strategies "That Work," Not "Expensive Vaccine Research," Opinion Piece Says (March 25, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Gates Foundation, Canadian Government Announce Joint Initiative to Develop HIV/AIDS Vaccine (February 21, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Ads Urge Youths to Help End AIDS by Volunteering for Vaccine Studies (October 11, 2006)
From National Institute of Allergy and Infectious Diseases
- Gates Foundation Pledges $287 Million for HIV Vaccine Research (July 20, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- African Americans: Answers About HIV Vaccine Research (June 2006)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
- World Risks Duplication in AIDS Vaccine Push, International AIDS Vaccine Initiative Official Says (September 14, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Canadian Network of Vaccine Researchers' National Funding Grant Not Renewed (July 20, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- NIAID Establishes Consortium to Research, Develop HIV Vaccines (July 18, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- NIAID Funds Center for HIV/AIDS Vaccine Immunology (July 14, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
- U.S. Spurs New Initiative on Vaccine Development -- But Some Critics Are Worried (June 15, 2004)
From MotherJones.com
- G8 Countries Agree to Form Global HIV Vaccine Consortium (June 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- G8 Summit Participants to Endorse Formation of HIV/AIDS Vaccine Consortium (June 9, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Interview With Anthony Fauci, M.D., Director of NIAID, on the HIV Vaccine Enterprise (Summer 2004)
An unofficial, international consortium seeks to coordinate vaccine development worldwide.
In Positives for Positives, from Wyoming: Positives for Positives
- Merck Vaccine Research Official to Join AIDS Vaccine Initiative (January 13, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- University of Alabama Wins $16 Million Grant to Develop Possible HIV Vaccine (August 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New York Times, Washington Post Examine Vaccine Projects of Bill & Melinda Gates Foundation (July 14, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- VaxGen Granted $2M to Continue HIV Vaccine Research (June 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Fighting AIDS: The Quest for an HIV Vaccine (May 19, 2003)
A statement from the HIV Research Section of the AIDS Office in the San Francisco Department of Public Health.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Merck and Aventis Will Combine HIV Vaccines (March 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- South African Scientists to Begin Manufacturing New Vaccines Aimed at Preventing AIDS (September 27, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- An AIDS Vaccine: When? (September/October 2002)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Scientists Optimistic That AIDS Vaccine Could Be Developed in Africa (June 4, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- NIAID Teams With Wyeth on HIV/AIDS Vaccine (May 17, 2002)
From U.S. National Institute of Allergy and Infectious Diseases
- HIV Vaccine Research Is "Best Hope" for Controlling AIDS Pandemic (May 16, 2002)
Fifth Annual HIV Vaccine Awareness Day to highlight progress, goals for future.
From U.S. National Institute of Allergy and Infectious Diseases
- What's in Glaxo's HIV Vaccine? (March 1, 2002)
In TAGline, from Treatment Action Group
- NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases
- NIAID and Merck to Collaborate on HIV Vaccine Development (December 20, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
- Closer to AIDS Vaccine? (September 5, 2001)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Fauci to Present AIDS Vaccine Update at Philadelphia Meeting (September 4, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
- Human AIDS Vaccine Trials Due in March 2002 (August 14, 2001)
From United Nations Integrated Regional Information Networks
- AIDS Vaccines and Activism: Interview with Jon Cohen (June 29, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
- Vaccine Vitriol: Call for Poor Country Focus on Treatment, Care Programs Elicits Voice of Concern from Vaccine Outfit (June 2001)
In TAGline, from Treatment Action Group
- New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys (March 8, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
- AIDS Research Past and Future: An Interview with Jeffrey Laurence, M.D. (December 2000)
From American Foundation for AIDS Research
- Perfect Vaccine for HIV Not Likely, Researcher Warns (November 2000)
In Body Positive, from Body Positive
- African Scientists Launch Vaccine Strategy for the Continent (July 13, 2000)
From UNAIDS
- Thai AIDS Vaccines (July 13, 2000)
(This is an audio file).
From National Public Radio
- NIH Announces New International Network to Study HIV Prevention Strategies (July 12, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
- News & Notes: TAG Finds Need for New Funding Priorities in Vaccine (June 2000)
In Body Positive, from Body Positive
- Resources for HIV Vaccine Research and Development (May 2000)
From U.S. National Institute of Allergy and Infectious Diseases
- Seven Years and Counting... How Can We Overcome Obstacles to an AIDS Vaccine? (PDF) (May 2000)
The annual report about AIDS vaccines.
From AIDS Vaccine Advocacy Coalition
- Vaccine News (March 17, 2000)
In AIDS Treatment News, from AIDS Treatment News
- AIDS Vaccine Advocacy Coalition
Up-to-date information and links related to citizen advocacy for HIV vaccines.
- HIV Vaccines in Canada: Legal and Ethical Issues
An overview paper and accompanying series of info sheets.
From Canadian HIV/AIDS Legal Network
Activism
- HIV Vaccine Awareness Day 2005: Statement by NIAID Director Anthony S. Fauci (May 18, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
- Men Inspiring Hope: Eighth Annual HIV Vaccine Awareness Day Focuses on Men Who Have Sex With Men (May 17, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
- Vaccine Trial RV144 Squanders Public Goodwill and Scarce Research Funds -- But to What End? (January 2005)
An AIDS advocacy group questions the wisdom of RV144, an ongoing "prime-boost" Phase III vaccine trial in Thailand.
In TAGline, from Treatment Action Group
- IAVI Statement on 2004 HIV/AIDS Statistics: New Technologies Key to Prevention (November 23, 2004)
Vaccines and microbicides could be key to reversing the growing HIV rate among women worldwide, the International AIDS Vaccine Initiative says.
From International AIDS Vaccine Initiative
- Seventh Annual HIV Vaccine Awareness Day Highlights Slow Progress on Development (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Atlanta to Hold Events for HIV Vaccine Awareness Day (May 17, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Brother-to-Brother Receives Funds to Raise Awareness About HIV Vaccine Research in Hard-to-Reach Populations (March 26, 2004)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- The Cure: We Get What We Demand (October 2003)
To read PDF, click here
In Project Inform Perspective, from Project Inform
- Top HIV/AIDS Researchers Push for Greater Vaccine Effort (June 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- International HIV Vaccine Awareness Day: May 18, 2003 (May 16, 2003)
From U.S. National Institute of Allergy and Infectious Diseases
- Many Americans Think an HIV/AIDS Vaccine Already Exists (May 15, 2003)
From U.S. National Institute of Allergy and Infectious Diseases
- Consensus Statement (March 2003)
In TAGline, from Treatment Action Group
- Net Return Plunges for AIDS Vaccine Rides (March 12, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Advocating for Improved AIDS Vaccine Policies (November 2001)
In OUTReach, from San Francisco AIDS Foundation
- Fourth Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research (May 14, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
- Third Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research (May 15, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
- Vaccines: Call Congress to Support R&D Tax Credit (April 21, 2000)
In AIDS Treatment News, from AIDS Treatment News
Recent Findings
- IAVI Report Online (Regularly Updated)
A centralized source of information on all aspects of AIDS vaccine research and associated scientific disciplines.
From International AIDS Vaccine Initiative
- The Failed HIV Vaccine, the HPV Vaccine Hullabaloo and the Future of HIV Prevention (January 2008)
To read PDF, click here
In HHS Watch, from Community HIV/AIDS Mobilization Project
- Merck HIV Vaccine Trial Results: Hopes Dim for Struggling Field (Winter 2008)
To read PDF, click here
In TAGline, from Treatment Action Group
- Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo (November 14, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Merck Halts International HIV Vaccine Trial (September 24, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate (September 21, 2007)
From Merck & Co., Inc.
- Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (September 1, 2007)
In Journal of Acquired Immune Deficiency Syndromes
- AIDS Vaccine Update (July-December 2007)
Disappointment and questions after candidate fails in the STEP study.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Male Circumcision Reduces Men's HIV Infection Risk by 65%, Data Re-Evaluation Says (February 23, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development (February 14, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- VAX Primer: Understanding the Early Stages of HIV Infection (April 2006)
How can studying what happens immediately following HIV infection help researchers design an AIDS vaccine?.
From International AIDS Vaccine Initiative
- Enrolling Women Into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge (February 21, 2006)
In PLoS Medicine
- HIV Vaccine's CD4+ Cell-Boosting Properties Lead Merck to Double Enrollment in Study (September 23, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- A Promising Alternative: Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges (August 2005)
A study by researchers at Emory University and Merck.
In PLoS Medicine
- Phase I Trial of Italian HIV Vaccine Trial Successful, Researchers Say; Phase II To Test Vaccine in Africa (July 7, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Health Affairs Focuses on Vaccines, Features Interview With Thompson; Kaiser Family Foundation Describes Media Campaigns (May 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- International AIDS Vaccine Initiative Releases Several Working Papers, Brief (April 26, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Treble Damages: Three Highlighted Studies From the AIDS Vaccine 2004 Conference (October 2004)
Disappointment clouded this year's conference, with new study results suggesting that current approaches to vaccine development aren't panning out.
In TAGline, from Treatment Action Group
- Slow but Real Progress on the AIDS Vaccine Front (September 3, 2004)
Highlights from the AIDS Vaccine 04 conference.
From aidsmap.com
- Researchers Identify Mutations That Help HIV Avoid Immune Detection; Implications for Vaccine Development (June 2, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Keystone HIV Pathogenesis and Vaccine Development Report (May/June 2004)
Highlights from the Keystone Symposia on Molecular Mechanisms of HIV Pathogenesis (X7) and HIV Vaccine Development (X8), April 12-18, 2004.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- HIV More Vulnerable to Vaccine During Acute Infection, Study Suggests (March 26, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases
- Researcher Loses HIV Vaccine Data in Durban Mugging (August 6, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Antibody Discovery Could Lead to HIV Vaccine: Study (July 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New HIV Vaccine Shows Promising Results in Preclinical Studies (June 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Nabbing the V3 Loop (May 2003)
Susan Zolla-Pazner offers new insight into why some anti-V3 loop antibodies have broad HIV neutralizing ability.
In TAGline, from Treatment Action Group
- Starting Anew (Again) (April 2003)
CROI 2003 updates on vaccines, siRNA therapy, CEM15 deactivation and the therapeutic value of GBV-C.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- AIDS Groups Call for Review of AIDS Vaccine Trial Results (March 31, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV's Ability to Rapidly Evolve Occurs Quicker Than Thought (March 21, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Virion-Based Vaccine Protects Macaques Against SIV (March 19, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First AIDS Vaccine Tested Did Not Protect, But Gives Scientific Leads (March 14, 2003)
In AIDS Treatment News, from AIDS Treatment News
- Stirring Up Racial Concerns (March 3, 2003)
The media comes under fire for overplaying AIDSVAX's poor study results, and underplaying its possible effectiveness in some minorities.
In San Francisco Chronicle
- AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close (March 2003)
In TAGline, from Treatment Action Group
- The VaxGen Study (Spring 2003)
In STEP Perspective, from Seattle Treatment Education Project
- Effectiveness of AIDS Vaccine May Be Overstated, Expert Says; Statistics Problem May Account for AIDSVAX Discrepancy (February 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Controversial HIV Vaccine Trial Results Disappointing (February 25, 2003)
From Canadian AIDS Treatment Information Exchange
- Official Hopes to Explain AIDS Vaccine Disparities (February 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First AIDS Vaccine in Large Test Found to Be Mostly Ineffective (February 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- NPR Reports on AIDSVAX Trial Results (RealAudio) (February 24, 2003)
From National Public Radio
- Experiment Shows AIDS Vaccine Unlikely to Give Total Protection From Disease (February 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Experimental AIDS Vaccine Being Tested on Humans (January 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The HIV/AIDS Vaccine Research Effort: An Update (January 2003)
Despite many challenges, a good amount of progress has been made.
In Hopkins HIV Report
- Willingness to Participate and Enroll in a Phase 3 Preventive HIV-1 Vaccine Trial (December 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- VaxGen's AIDS Vaccine to Be Reviewed by FDA (December 17, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Trick Helps Explain Failed Vaccine Attempts (December 13, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Research From the 42nd ICAAC: Alpha-Defensins, Non-Progressors and Vaccines (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- HIV's Success Might Lie in Its Mutations (November 6, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- St. Louisan with HIV Is Fighting Off AIDS (September 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Researchers Document Rare Case of Second HIV Infection With Different Strain (September 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Expert Opinion From Barcelona: Vaccines (September/October 2002)
In Positively Aware, from Test Positive Aware Network
- HIV-Specific CD8 T-Cell Activity in Uninfected Injection Drug Users Is Associated With Maintenance of Seronegativity (August 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV-1 Superinfection: AE Subtype Supplanted by B Subtype (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Hope for AIDS Vaccine Fades; News of Superinfection Case (July 11, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Harnessing the Immune System to Fight HIV (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Immune Responses in Long-Term Non-Progressors -- Lessons for Immune Reconstitution (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Sign of HIV Immunity Reported; Protective Responses Suspected in Two Studies (July 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Selectively Suppresses Anti-HIV Defense Cells (May 1, 2002)
From U.S. National Institute of Allergy and Infectious Diseases
- Chimp Adenovirus as New Vaccine Vector (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- Franchini's DNA Prime and NYVAC Boost Vaccine (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- Not to Be Sneezed At: Merck's HIV Vaccine Program (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- AIDS Vaccine Moves Ahead in Trials (April 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Impact of Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model (March 7, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Promise of New Vaccine Vectors, the Perils of Partial Protection (March 1, 2002)
Two new HIV vaccine studies published in the journal Nature.
In TAGline, from Treatment Action Group
- Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV (November 2001)
In TAGline, from Treatment Action Group
- Vaccine Stops Vaginal Transmission of HIV-Like Virus (July 23, 2001)
From Reuters Health
- Simian Success (January 2001)
Vaccine study seen as significant advance, but questions remain about human applicability.
In TAGline, from Treatment Action Group
- Status Report on HIV Vaccine Development (Winter 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vaccine Advance: Monkeys Still Infected, but Protected from Illness (October 20, 2000)
In AIDS Treatment News, from AIDS Treatment News
- New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment (September 22, 2000)
A study in monkeys has provided important information on how the immune response to HIV develops, why it is usually not sufficient, and how vaccine approaches might be tested more effectively in the future.
In AIDS Treatment News, from AIDS Treatment News
- Promising HIV Vaccine Strategy Identified in Monkey Studies (September 20, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
- Vaccine Notes from the Cent Gardes (January 2000)
In TAGline, from Treatment Action Group
|
|
